My Stocks Explore Events Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Please signup to use this feature
Live today
{{event.ticker}} @{{event.event_utc_datetime | date:'h:mm a'}}
{{market.market_short_name}} {{market.last_price | number : 2}}
AlphaStreet

Want to join the conversation?


$HALO {{ '2015-08-10T21:14:46+0000' | timeago}} • Webcast

$HALO 2Q15 Call: Research and development expenses for the 2Q15 were $21.2MM compared to $18.6MM in 2Q14. The increase was primarily due to an increase in expenses related to preclinical and clinical activities for PEGPH20, off-set by a planned decrease in expenses associated with discontinued development programs.

User Robert Smith {{ '2017-04-26T21:13:12+0000' | timeago}}

$PYPL jumps 6% in after hours on strong results. I am bullish on this stock.

User Leroy John {{ '2017-04-26T21:11:32+0000' | timeago}}

$TSCO stock remained active in the after hours trading and rose more than 2% after the retailer posted better than expected 1Q17 results.

User Irene Grennan {{ '2017-04-26T21:08:01+0000' | timeago}}

Instagram has reached 700 million monthly active users. Looks like it will hit 1 billion soon. That would make it $FB’s fourth billion-user platform.

User Barbara Salley {{ '2017-04-26T17:50:03+0000' | timeago}}

Back with a bang! $TWTR

User Amelita Yates {{ '2017-04-26T17:23:10+0000' | timeago}}

Even though $TMUS is behind $VZ and $T, it is playing catchup in style! 1.1 million new subscribers in Q1!!

$LUV {{ '2017-04-27T11:16:47+0000' | timeago}} • Webcast

$LUV's operating revenue inched 1.2% to $4.88Bil in 1Q17, as it posted a 31.6% drop in net income of $351MM from last year's $513MM. Earnings slid 27.8% to $0.57 per diluted share, as Southwest Airlines recorded an 8.8% increase in total operating expenses of $4.23Bil for the quarter.

$MPC {{ '2017-04-27T11:16:27+0000' | timeago}} • Announcement

$MPC reported a rise in 1Q17 earnings driven by solid contributions from the Speedway and Midstream segments as well as higher revenue. Net income rose to $30MM or $0.06 per share from $1MM or $0.003 per share last year. Revenue grew to $16.4Bil from $12.8Bil.

$BSX {{ '2017-04-27T11:16:23+0000' | timeago}} • Announcement

$BSX estimates sales for 2Q17 in a range of $2.185-2.215Bil and earnings between $0.18 and $0.21 per share. Adjusted earnings were predicted to be between $0.30 and $0.32 per share.

$BSX {{ '2017-04-27T11:12:47+0000' | timeago}} • Announcement

$BSX now estimates revenue for FY17 in a range of $8.8-8.9Bil (compared to prior guidance of $8.675-8.875Bil). Net income is expected between $0.81 and $0.86 per share (compared to prior guidance of $0.86-0.91 per share). Adjusted earnings outlook was reaffirmed at a range of $1.22-1.26 per share.

$BSX {{ '2017-04-27T11:08:18+0000' | timeago}} • Announcement

$BSX's sales in 1Q17 rose to $2.16Bil, helped by revenue growth in all segments. In a YoY basis, MedSurg revenue jumped 15%; Cardiovascular grew 8%; and Rhythm Management increased 7%.